GSTC Stock Chart & Stats
<$0.01
>-$0.01(-99.00%)
At close: 4:00 PM EDT
<$0.01
>-$0.01(-99.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.27K
Average Volume (3M)N/A
Market Cap
$1.24K
Enterprise Value$490.12K
Total Cash (Recent Filing)$41.00
Total Debt (Recent Filing)$329.05K
Price to Earnings (P/E)―
Beta12.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,241,105,700
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-1.04
Price to Sales (P/S)0.00
P/FCF Ratio-7.24
Enterprise Value/Market Cap394.94
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSTC FAQ
What was GlobeStar Therapeutics’s price range in the past 12 months?
GlobeStar Therapeutics lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is GlobeStar Therapeutics’s market cap?
GlobeStar Therapeutics’s market cap is $1.24K.
When is GlobeStar Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GlobeStar Therapeutics’s earnings last quarter?
GlobeStar Therapeutics released its earnings results on Feb 15, 2018. The company reported -$0.009 earnings per share for the quarter.
Is GlobeStar Therapeutics overvalued?
According to Wall Street analysts GlobeStar Therapeutics’s price is currently Overvalued.
Does GlobeStar Therapeutics pay dividends?
GlobeStar Therapeutics does not currently pay dividends.
What is GlobeStar Therapeutics’s EPS estimate?
GlobeStar Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlobeStar Therapeutics have?
GlobeStar Therapeutics has 1,241,105,700 shares outstanding.
What happened to GlobeStar Therapeutics’s price movement after its last earnings report?
GlobeStar Therapeutics reported an EPS of -$0.009 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of GlobeStar Therapeutics?
Currently, no hedge funds are holding shares in GSTC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GlobeStar Therapeutics
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.